Evidence map›Paper›PMID 26740587›Full record

ArticleOpen biology2016

Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine.

Anna Ligasová, Radek Liboska, David Friedecký, Kateřina Mičová, Tomáš Adam, Tomáš Oždian, Ivan Rosenberg, Karel Koberna

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Cytidine and dCMP Deaminases-Current Methods of Activity Analysis.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Nucleotide excision repair removes thymidine analog 5-ethynyl-2'-deoxyuridine from the mammalian genome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Early Nuclear Events after Herpesviral Infection.Journal of clinical medicine · 2019
    Review
  16. Article
  17. Article
  18. DNA Replication: From Radioisotopes to Click Chemistry.Molecules (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anna LigasováInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic anna.ligasova@upol.cz.
Radek LiboskaInstitute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
David FriedeckýInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
Kateřina MičováInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
Tomáš AdamInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
Tomáš OždianInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
Ivan RosenbergInstitute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
Karel KobernaInstitute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic karel.koberna@upol.cz.
Institute of Molecular and Translational Medicine · CZCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZPalacký University Olomouc · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.

Indexed as

AntibodiesBromodeoxyuridineCell DeathCell Line, TumorCell NucleusCytidine DeaminaseDeoxycytidineDeoxyuridineDNADNA ReplicationHumansMetabolomeRNA, Small Interfering5-ethynyl-2'-deoxycytidine5-ethynyl-2'-deoxyuridineAntibodiesBromodeoxyuridineCytidine DeaminaseDeoxycytidineDeoxyuridineDNARNA, Small Interfering5-ethynyl-2′-deoxycytidine5-ethynyl-2′-deoxyuridinecytidine deaminasedCMP deaminaseDNA replication

Identifiers

PMID26740587
PMCPMC4736823
OpenAlexW2269239426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.